Browse studies
Find your next paid study
2 recruiting studies matching your filters
Phase 1
A Phase I, Randomized, Double-Blind Study to Evaluate the Safety and Tolerability of AV-1980R in Participants With Preclinical Alzheimer's Disease
This is a Phase 1, multicenter, randomized, double-blind, placebo-controlled, multiple-dose-escalation study evaluating the safety, tolerability, and immunogen…
Alzheimer DiseasePreclinical Alzheimer's Disease
Estimated
~$10 – $7,500
Institute for Molecular MedicineNCT07158905
Phase 2
The Alzheimer's Disease Tau Platform Clinical Trial
The goal of the Alzheimer's Tau Platform (ATP) is to evaluate the safety and effectiveness of tau-directed therapies, alone or in combination with the anti-amy…
Preclinical Alzheimer's DiseaseAlzheimer DiseaseProdromal Alzheimer's Disease
Estimated
~$10 – $7,500
Paul S. AisenNCT06957418